SK Capital Announces Agreement to Acquire Perrigo Company plc’s Active Pharmaceutical Ingredients Business

Go back to SK Capital Announces Agreement to Acquire Perrigo Company plc’s Active Pharmaceutical Ingredients Business

Perrigo Co. (PRGO) PT Raised to $71 at Jefferies; Reiterates Hold

August 11, 2017 8:17 AM EDT

Jefferies raised its price target on Perrigo Co. (NYSE: PRGO) to $71.00 (from $69.00) while maintaining a Hold rating. Jefferies increased FY17 revenues and EPS estimates by $84M and $0.25 to $4.80B and $.4.54 vs managements guidance of $4.70-4.85B and $4.45-4.70. Primarily reflecting encouraging signs of a... More

Perrigo Co. (PRGO) PT Raised to $93 at Cantor Fitzgerald

August 10, 2017 12:49 PM EDT

Cantor Fitzgerald analyst Louise Chen raised her price target on Perrigo Co. (NYSE: PRGO) to $93.00 (from $85.00) while maintaining an Overweight rating amid upwards earnings revisions and multiple expansion.

Chen commented, "Perrigo has been through a lot over the past two years,... More